AAAAAA
Results:
1-11
|
Results: 11
Authors:
MACKEY JR
VENNER P
Citation: Jr. Mackey et P. Venner, SEMINOMA WITH ISOLATED CENTRAL-NERVOUS-SYSTEM RELAPSE, AND SALVAGE WITH CRANIOSPINAL IRRADIATION, Urology, 51(6), 1998, pp. 1043-1045
Authors:
GLEAVE ME
ELHILALI M
FRADET Y
DAVIS I
VENNER P
SAAD F
KLOTZ LH
MOORE MJ
PATON V
BAJAMONDE A
Citation: Me. Gleave et al., INTERFERON GAMMA-1B COMPARED WITH PLACEBO IN METASTATIC RENAL-CELL CARCINOMA, The New England journal of medicine, 338(18), 1998, pp. 1265-1271
Authors:
MACKEY JR
AU HJ
HUGH J
VENNER P
Citation: Jr. Mackey et al., GENITOURINARY SMALL-CELL CARCINOMA - DETERMINATION OF CLINICAL AND THERAPEUTIC FACTORS ASSOCIATED WITH SURVIVAL, The Journal of urology, 159(5), 1998, pp. 1624-1629
Authors:
SCHELLHAMMER PF
VENNER P
HAAS GP
SMALL EJ
NIEH PT
SEABAUGH DR
PATTERSON AL
KLEIN E
WAJSMAN Z
FURR B
CHEN YS
KOLVENBAG GJCM
Citation: Pf. Schellhammer et al., PROSTATE-SPECIFIC ANTIGEN DECREASES AFTER WITHDRAWAL OF ANTIANDROGEN THERAPY WITH BICALUTAMIDE OR FLUTAMIDE IN PATIENTS RECEIVING COMBINED ANDROGEN BLOCKADE, The Journal of urology, 157(5), 1997, pp. 1731-1735
Authors:
TESTER W
CAPLAN R
HEANEY J
VENNER P
WHITTINGTON R
BYHARDT R
TRUE L
SHIPLEY W
Citation: W. Tester et al., NEOADJUVANT COMBINED-MODALITY PROGRAM WITH SELECTIVE ORGAN PRESERVATION FOR INVASIVE BLADDER-CANCER - RESULTS OF RADIATION-THERAPY ONCOLOGYGROUP PHASE-II TRIAL 8802, Journal of clinical oncology, 14(1), 1996, pp. 119-126
Authors:
SOLOWAY MS
SCHELLHAMMER P
SHARIFI R
VENNER P
PATTERSON AL
SAROSDY M
VOGELZANG N
JONES J
KOLVENBAG G
Citation: Ms. Soloway et al., A CONTROLLED TRIAL OF CASODEX(TM) (BICALUTAMIDE) VS FLUTAMIDE, EACH IN COMBINATION WITH LUTEINIZING-HORMONE-RELEASING HORMONE ANALOG THERAPY IN PATIENTS WITH ADVANCED PROSTATE-CANCER, European urology, 29, 1996, pp. 105-109
Authors:
SCHELLHAMMER P
SHARIFI R
BLOCK N
SOLOWAY M
VENNER P
PATTERSON AL
SAROSDY M
VOGELZANG N
JONES J
KOLVENBAG G
Citation: P. Schellhammer et al., MAXIMAL ANDROGEN BLOCKADE FOR PATIENTS WITH METASTATIC PROSTATE-CANCER - OUTCOME OF A CONTROLLED TRIAL OF BICALUTAMIDE VERSUS FLUTAMIDE, EACH IN COMBINATION WITH LUTEINIZING-HORMONE-RELEASING HORMONEANALOGUE THERAPY, Urology, 47(1A), 1996, pp. 54-60
Authors:
SCHELLHAMMER P
SHARIFI R
BLOCK N
SOLOWAY M
VENNER P
PATTERSON AL
SAROSDY M
VOGELZANG N
JONES J
KOLVENBAG G
Citation: P. Schellhammer et al., A CONTROLLED TRIAL OF BICALUTAMIDE VERSUS FLUTAMIDE, EACH IN COMBINATION WITH LUTEINIZING-HORMONE-RELEASING HORMONE ANALOG THERAPY, IN PATIENTS WITH ADVANCED PROSTATE-CANCER, Urology, 45(5), 1995, pp. 745-752
Authors:
MOORE MJ
OSOBA D
MURPHY K
TANNOCK IF
ARMITAGE A
FINDLAY B
COPPIN C
NEVILLE A
VENNER P
WILSON J
Citation: Mj. Moore et al., USE OF PALLIATIVE END-POINTS TO EVALUATE THE EFFECTS OF MITOXANTRONE AND LOW-DOSE PREDNISONE IN PATIENTS WITH HORMONALLY RESISTANT PROSTATE-CANCER, Journal of clinical oncology, 12(4), 1994, pp. 689-694
Authors:
MERTENS WC
EISENHAUER EA
MOORE M
VENNER P
STEWART D
MULDAL A
WONG D
Citation: Wc. Mertens et al., GEMCITABINE IN ADVANCED RENAL-CELL CARCINOMA - A PHASE-II STUDY OF THE NATIONAL-CANCER-INSTITUTE OF CANADA-CLINICAL-TRIALS-GROUP, Annals of oncology, 4(4), 1993, pp. 331-332
Authors:
TESTER W
PORTER A
ASBELL S
COUGHLIN C
HEANEY J
KRALL J
MARTZ K
VENNER P
HAMMOND E
Citation: W. Tester et al., COMBINED MODALITY PROGRAM WITH POSSIBLE ORGAN PRESERVATION FOR INVASIVE BLADDER-CARCINOMA - RESULTS OF RTOG PROTOCOL 85-12, International journal of radiation oncology, biology, physics, 25(5), 1993, pp. 783-790
Risultati:
1-11
|